Literature DB >> 33368687

Serum ACE as a prognostic biomarker in COVID-19: a case series.

Espen Skarstein Kolberg1,2, Kristin Wickstrøm3, Kristian Tonby4,5, Anne Ma Dyrhol-Riise4,5, Aleksander Rygh Holten5,6, Erik Koldberg Amundsen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33368687     DOI： 10.1111/apm.13108

Source DB:  PubMed          Journal:  APMIS        ISSN： 0903-4641            Impact factor:   3.205


× No keyword cloud information.
  3 in total

1.  The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19-A Prospective Pilot Study.

Authors:  Reut Kassif Lerner; Michal Stein Yeshurun; Rina Hemi; Nahid Zada; Keren Asraf; Ram Doolman; Stefanie W Benoit; Maria Helena Santos de Oliveira; Giuseppe Lippi; Brandon Michael Henry; Itai M Pessach; Naomi Pode Shakked
Journal:  J Pers Med       Date:  2022-04-12

2.  Angiotensin System Polymorphisms' in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study.

Authors:  Concetta Cafiero; Felice Rosapepe; Raffaele Palmirotta; Agnese Re; Maria Pia Ottaiano; Giulio Benincasa; Romina Perone; Elisa Varriale; Gerardo D'Amato; Andrea Cacciamani; Alessandra Micera; Salvatore Pisconti
Journal:  Pharmgenomics Pers Med       Date:  2021-05-27

3.  Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19.

Authors:  Lukas Hartl; Mathias Jachs; Benedikt Simbrunner; David J M Bauer; Georg Semmler; Daniela Gompelmann; Thomas Szekeres; Peter Quehenberger; Michael Trauner; Mattias Mandorfer; Bernhard Scheiner; Thomas Reiberger
Journal:  J Pers Med       Date:  2021-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.